Balyasny Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-225,000
Closed -$3.95M 2475
2021
Q3
$3.95M Buy
+225,000
New +$3.95M 0.02% 745
2020
Q4
Sell
-234,122
Closed -$3.33M 1602
2020
Q3
$3.33M Buy
+234,122
New +$3.33M 0.02% 563
2020
Q2
Sell
-326,065
Closed -$1.32M 1443
2020
Q1
$1.32M Buy
+326,065
New +$1.32M 0.02% 586